Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Clinical Senior Lecturer in Respiratory Fungal Diseases



+44 (0)20 7594 2746d.armstrong




5.30Flowers buildingSouth Kensington Campus





I am a clinical senior lecturer in respiratory fungal diseases at the National Heart and Lung Institute, Imperial College London and honorary consultant physician in infectious diseases and medical mycology to the Royal Brompton and Harefield NHS Trust. My research is primarily on innate immunity to Aspergillus fumigatus with a particular focus on macrophage cell biology and signal transduction. In addition I am involved in clinical translation relevant to medical mycology.

I initially studied Trypanosomal peroxidases with John Kelly and David Horn at the London School of Hygiene and Tropical Medicine during my MSc in pathogen Molecular Biology. I went on to undertake my PhD with Ken Haynes and Tom Rogers at Imperial on fungal host adaptation. I was subsequently awarded a MRC Clinician Scientist Fellowship to retrain in immunology and established the fungal immunobiology laboratory at Imperial. I have recently moved to the NHLI to further support the development of academic medical mycology and clinical infectious diseases at the NHLI and Royal Brompton and Harefield.  



Armstrong-James D, Brown GD, Netea MG, et al., 2017, Immunotherapeutic approaches to treatment of fungal diseases., Lancet Infect Dis

Amarsaikhan N, Sands EM, Shah A, et al., 2017, Caspofungin Increases Fungal Chitin and Eosinophil and γδ T Cell-Dependent Pathology in Invasive Aspergillosis., J Immunol, Vol:199, Pages:624-632

Armstrong-James D, Bicanic T, Brown GD, et al., 2017, AIDS-Related Mycoses: Current Progress in the Field and Future Priorities., Trends Microbiol, Vol:25, Pages:428-430

Cutino-Moguel M-T, Eades C, Rezvani K, et al., 2017, Immunotherapy for infectious diseases in haematological immunocompromise., Br J Haematol, Vol:177, Pages:348-356

Alsuliman A, Muftuoglu M, Khoder A, et al., 2017, A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML., Blood, Vol:129, Pages:740-758

More Publications